Deep brain stimulation for treatment-refractory obsessive compulsive disorder: a systematic review

Sina Kohl, Deva M Schönherr, Judy Luigjes, Damiaan Denys, Ulf J Mueller, Doris Lenartz, Veerle Visser-Vandewalle, Jens Kuhn, Sina Kohl, Deva M Schönherr, Judy Luigjes, Damiaan Denys, Ulf J Mueller, Doris Lenartz, Veerle Visser-Vandewalle, Jens Kuhn

Abstract

Background: Obsessive-compulsive disorder is one of the most disabling of all psychiatric illnesses. Despite available pharmacological and psychotherapeutic treatments about 10% of patients remain severely affected and are considered treatment-refractory. For some of these patients deep brain stimulation offers an appropriate treatment method. The scope of this article is to review the published data and to compare different target structures and their effectiveness.

Methods: PubMed search, last update June 2013, was conducted using the terms "deep brain stimulation" and "obsessive compulsive disorder".

Results: In total 25 studies were found that reported five deep brain stimulation target structures to treat obsessive-compulsive disorder: the anterior limb of the internal capsule (five studies including 14 patients), nucleus accumbens (eight studies including 37 patients), ventral capsule/ventral striatum (four studies including 29 patients), subthalamic nucleus (five studies including 23 patients) and inferior thalamic peduncle (two studies including 6 patients). Despite the anatomical diversity, deep brain stimulation treatment results in similar response rates for the first four target structures. Inferior thalamic peduncle deep brain stimulation results in higher response rates but these results have to be interpreted with caution due to a very small number of cases. Procedure and device related adverse events are relatively low, as well as stimulation or therapy related side effects. Most stimulation related side effects are transient and decline after stimulation parameters have been changed.

Conclusion: Deep brain stimulation in treatment-refractory obsessive-compulsive disorder seems to be a relatively safe and promising treatment option. However, based on these studies no superior target structure could be identified. More research is needed to better understand mechanisms of action and response predictors that may help to develop a more personalized approach for these severely affected obsessive compulsive patients.

Figures

Figure 1
Figure 1
PRISMA flowchart. Process of literature search (Flowchart taken from Moher, [21]).
Figure 2
Figure 2
Target locations. Reconstructed targets onto coronal (a) and horizontal (b, c) sections. NAc: Nucleus accumbens; ALIC: Anterior limb of the internal capsule; VS: ventral striatum; BST: Bed nucleus of the stria terminalis; ITP: Inferior thalamic peduncle; STN: subthalamic nucleus.

References

    1. Murray CJ, Lopez AD. Evidence-based health policy–lessons from the Global Burden of Disease Study. Science. 1996;274(5288):740–743. doi: 10.1126/science.274.5288.740.
    1. Robins LN, Helzer JE, Weissman MM, Orvaschel H, Gruenberg E, Burke JD, Jr, Regier DA. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry. 1984;41(10):949–958. doi: 10.1001/archpsyc.1984.01790210031005.
    1. McIntyre CC, Hahn PJ. Network perspectives on the mechanisms of deep brain stimulation. Neurobiol Dis. 2010;38(3):329–337. doi: 10.1016/j.nbd.2009.09.022.
    1. Modell JG, Mountz JM, Curtis GC, Greden JF. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci. 1989;1(1):27–36.
    1. Beucke JC, Sepulcre J, Talukdar T, Linnman C, Zschenderlein K, Endrass T, Kaufmann C, Kathmann N. Abnormally high degree connectivity of the orbitofrontal cortex in obsessive-compulsive disorder. JAMA Psychiatry. 2013;70(6):619–629. doi: 10.1001/jamapsychiatry.2013.173.
    1. Ahmari SE, Spellman T, Douglass NL, Kheirbek MA, Simpson HB, Deisseroth K, Gordon JA, Hen R. Repeated cortico-striatal stimulation generates persistent OCD-like behavior. Science. 2013;340(6137):1234–1239. doi: 10.1126/science.1234733.
    1. Denys D. Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders. Psychiatr Clin North Am. 2006;29(2):553–584. doi: 10.1016/j.psc.2006.02.013.
    1. Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol. 1987;50(1–6):344–346.
    1. Kuhn J, Grundler TO, Lenartz D, Sturm V, Klosterkotter J, Huff W. Deep brain stimulation for psychiatric disorders. Dtsch Arztebl Int. 2010;107(7):105–113.
    1. McCracken CB, Grace AA. Nucleus accumbens deep brain stimulation produces region-specific alterations in local field potential oscillations and evoked responses in vivo. J Neurosci. 2009;29(16):5354–5363. doi: 10.1523/JNEUROSCI.0131-09.2009.
    1. Dell'Osso B, Altamura AC, Allen A, Hollander E. Brain stimulation techniques in the treatment of obsessive-compulsive disorder: current and future directions. CNS Spectr. 2005;10(12):966–979.
    1. Denys D, Mantione M, Figee M, van den Munckhof P, Koerselman F, Westenberg H, Bosch A, Schuurman R. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch Gen Psychiatry. 2010;67(10):1061–1068. doi: 10.1001/archgenpsychiatry.2010.122.
    1. Nuttin B, Cosyns P, Demeulemeester H, Gybels J, Meyerson B. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet. 1999;354(9189):1526. doi: 10.1016/S0140-6736(99)02376-4.
    1. Kuhn J, Lenartz D, Mai JK, Huff W, Lee SH, Koulousakis A, Klosterkoetter J, Sturm V. Deep brain stimulation of the nucleus accumbens and the internal capsule in therapeutically refractory Tourette-syndrome. J Neurol. 2007;254(7):963–965. doi: 10.1007/s00415-006-0404-8.
    1. Vandewalle V, van der Linden C, Groenewegen HJ, Caemaert J. Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus. Lancet. 1999;353(9154):724. doi: 10.1016/S0140-6736(98)05964-9.
    1. Kuhn J, Lenartz D, Huff W, Lee S, Koulousakis A, Klosterkoetter J, Sturm V. Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: valuable therapeutic implications? J Neurol Neurosurg Psychiatry. 2007;78(10):1152–1153. doi: 10.1136/jnnp.2006.113092.
    1. Muller UJ, Voges J, Steiner J, Galazky I, Heinze HJ, Moller M, Pisapia J, Halpern C, Caplan A, Bogerts B, Kuhn J. Deep brain stimulation of the nucleus accumbens for the treatment of addiction. Ann N Y Acad Sci. 2013;1282:119–128. doi: 10.1111/j.1749-6632.2012.06834.x.
    1. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb JM, Kennedy SH. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45(5):651–660. doi: 10.1016/j.neuron.2005.02.014.
    1. Figee M, Luigjes J, Smolders R, Valencia-Alfonso CE, van Wingen G, de Kwaasteniet B, Mantione M, Ooms P, de Koning P, Vulink N, Levar N, Droge L, van den Munckhof P, Schuurman PR, Nederveen A, van den Brink W, Mazaheri A, Vink M, Denys D. Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder. Nat Neurosci. 2013;16(4):386–387. doi: 10.1038/nn.3344.
    1. Luigjes J, de Kwaasteniet BP, de Koning PP, Oudijn MS, van den Munckhof P, Schuurman PR, Denys D. Surgery for psychiatric disorders. World Neurosurg. 2013;80(3–4):S31 e17-28.
    1. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097.
    1. Mindus P, Rasmussen SA, Lindquist C. Neurosurgical treatment for refractory obsessive-compulsive disorder: implications for understanding frontal lobe function. J Neuropsychiatry Clin Neurosci. 1994;6(4):467–477.
    1. Nuttin B, Gabriels LA, Cosyns PR, Meyerson BA, Andreewitch S, Sunaert SG, Maes AF, Dupont PJ, Gybels JM, Gielen F, Demeulemeester HG. Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder. Neurosurgery. 2003;52(6):1263–1272. doi: 10.1227/01.NEU.0000064565.49299.9A.
    1. Gabriels L, Cosyns P, Nuttin B, Demeulemeester H, Gybels J. Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psychopathological and neuropsychological outcome in three cases. Acta Psychiatr Scand. 2003;107(4):275–282. doi: 10.1034/j.1600-0447.2003.00066.x.
    1. Anderson D, Ahmed A. Treatment of patients with intractable obsessive-compulsive disorder with anterior capsular stimulation. Case report J Neurosurg. 2003;98(5):1104–1108. doi: 10.3171/jns.2003.98.5.1104.
    1. Abelson JL, Curtis GC, Sagher O, Albucher RC, Harrigan M, Taylor SF, Martis B, Giordani B. Deep brain stimulation for refractory obsessive-compulsive disorder. Biol Psychiat. 2005;57(5):510–516. doi: 10.1016/j.biopsych.2004.11.042.
    1. Servello D, Sassi M, Bastianello S, Poloni GU, Mancini F, Pacchetti C. Electrode displacement after intracerebral hematoma as a complication of a deep brain stimulation procedure. Neuropsychiatr Dis Treat. 2009;5:183–187.
    1. Okun MS, Mann G, Foote KD, Shapira NA, Bowers D, Springer U, Knight W, Martin P, Goodman WK. Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming. J Neurol Neurosurg Psychiatry. 2007;78(3):310–314. doi: 10.1136/jnnp.2006.095315.
    1. Mogenson GJ, Yang CR. The contribution of basal forebrain to limbic-motor integration and the mediation of motivation to action. Adv Exp Med Biol. 1991;295:267–290. doi: 10.1007/978-1-4757-0145-6_14.
    1. Sturm V, Lenartz D, Koulousakis A, Treuer H, Herholz K, Klein JC, Klosterkotter J. The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. J Chem Neuroanat. 2003;26(4):293–299. doi: 10.1016/j.jchemneu.2003.09.003.
    1. Huff W, Lenartz D, Schormann M, Lee SH, Kuhn J, Koulousakis A, Mai J, Daumann J, Maarouf M, Klosterkotter J, Sturm V. Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: Outcomes after one year. Clin Neurol Neurosurg. 2010;112(2):137–143. doi: 10.1016/j.clineuro.2009.11.006.
    1. Aouizerate B, Cuny E, Martin-Guehl C, Guehl D, Amieva H, Benazzouz A, Fabrigoule C, Allard M, Rougier A, Bioulac B, Tignol J, Burbaud P. Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report J Neurosurg. 2004;101(4):682–686. doi: 10.3171/jns.2004.101.4.0682.
    1. Plewnia C, Schober F, Rilk A, Buchkremer G, Reimold M, Wachter T, Breit S, Weiss D, Kruger R, Freudenstein D. Sustained improvement of obsessive-compulsive disorder by deep brain stimulation in a woman with residual schizophrenia. Int J Neuropsychopharmacol. 2008;11(8):1181–1183. doi: 10.1017/S1461145708009188.
    1. Shimizu E. [Definition of treatment-refractory obsessive-compulsive disorder based on cognitive behavioral therapy] Seishin Shinkeigaku Zasshi. 2013;115(9):975–980.
    1. Franzini A, Messina G, Gambini O, Muffatti R, Scarone S, Cordella R, Broggi G. Deep-brain stimulation of the nucleus accumbens in obsessive compulsive disorder: clinical, surgical and electrophysiological considerations in two consecutive patients. Neurol Sci. 2010;31(3):353–359. doi: 10.1007/s10072-009-0214-8.
    1. Roh D, Chang WS, Chang JW, Kim CH. Long-term follow-up of deep brain stimulation for refractory obsessive-compulsive disorder. Psychiatry Res. 2012;200(2–3):1067–1070. doi: 10.1016/j.psychres.2012.06.018.
    1. Barcia JA, Reyes L, Arza R, Saceda J, Avecillas J, Yanez R, Garcia-Albea J, Ortiz T, Lopez-Ibor MI, Lopez-Ibor JJ. Deep Brain Stimulation for Obsessive-Compulsive Disorder: Is the Side Relevant? Stereotact Funct Neurosurg. 2013;92(1):31–36. doi: 10.1159/000353187.
    1. Corveleyn P, Nuttin B, Gabriels L. Deep brain stimulation in a patient with ocd and the intensive pre- and post-operative psychiatric/psychotherapeutic follow-up. A case study. Tijdschr Psychiatr. 2013;55(3):203–208.
    1. Greenberg BD, Malone DA, Friehs GM, Rezai AR, Kubu CS, Malloy PF, Salloway SP, Okun MS, Goodman WK, Rasmussen SA. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology. 2006;31(11):2384–2393. doi: 10.1038/sj.npp.1301165.
    1. Greenberg BD, Gabriels LA, Malone DA, Jr, Rezai AR, Friehs GM, Okun MS, Shapira NA, Foote KD, Cosyns PR, Kubu CS, Malloy PF, Salloway SP, Giftakis JE, Rise MT, Machado AG, Baker KB, Stypulkowski PH, Goodman WK, Rasmussen SA, Nuttin BJ. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry. 2010;15(1):64–79. doi: 10.1038/mp.2008.55.
    1. Goodman WK, Foote KD, Greenberg BD, Ricciuti N, Bauer R, Ward H, Shapira NA, Wu SS, Hill CL, Rasmussen SA, Okun MS. Deep brain stimulation for intractable obsessive compulsive disorder: pilot study using a blinded, staggered-onset design. Biol Psychiat. 2010;67(6):535–542. doi: 10.1016/j.biopsych.2009.11.028.
    1. Tsai HC, Chang CH, Pan JI, Hsieh HJ, Tsai ST, Hung HY, Chen SY. Pilot study of deep brain stimulation in refractory obsessive-compulsive disorder ethnic Chinese patients. Psychiatry Clin Neurosci. 2012;66(4):303–312. doi: 10.1111/j.1440-1819.2012.02352.x.
    1. Mallet L, Mesnage V, Houeto JL, Pelissolo A, Yelnik J, Behar C, Gargiulo M, Welter ML, Bonnet AM, Pillon B, Cornu P, Dormont D, Pidoux B, Allilaire JF, Agid Y. Compulsions, Parkinson’s disease, and stimulation. Lancet. 2002;360(9342):1302–1304. doi: 10.1016/S0140-6736(02)11339-0.
    1. Fontaine D, Mattei V, Borg M, von Langsdorff D, Magnie MN, Chanalet S, Robert P, Paquis P. Effect of subthalamic nucleus stimulation on obsessive-compulsive disorder in a patient with Parkinson disease. Case report J Neurosurg. 2004;100(6):1084–1086. doi: 10.3171/jns.2004.100.6.1084.
    1. Mallet L, Polosan M, Jaafari N, Baup N, Welter ML, Fontaine D, du Montcel ST, Yelnik J, Chereau I, Arbus C, Raoul S, Aouizerate B, Damier P, Chabardès S, Czernecki V, Ardouin C, Krebs MO, Bardinet E, Chaynes P, Burbaud P, Cornu P, Derost P, Bougerol T, Bataille B, Mattei V, Dormont D, Devaux B, Vérin M, Houeto JL, Pollak P, et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med. 2008;359(20):2121–2134. doi: 10.1056/NEJMoa0708514.
    1. Chabardes S, Polosan M, Krack P, Bastin J, Krainik A, David O, Bougerol T, Benabid AL. Deep brain stimulation for obsessive-compulsive disorder: subthalamic nucleus target. World Neurosurg. 2013;80(3–4):S31 e31-38.
    1. Jimenez-Ponce F, Velasco-Campos F, Castro-Farfan G, Nicolini H, Velasco AL, Salin-Pascual R, Trejo D, Criales JL. Preliminary study in patients with obsessive-compulsive disorder treated with electrical stimulation in the inferior thalamic peduncle. Neurosurgery. 2009;65(6 Suppl):203–209.
    1. Jimenez F, Nicolini H, Lozano AM, Piedimonte F, Salin R, Velasco F. Electrical stimulation of the inferior thalamic peduncle in the treatment of major depression and obsessive compulsive disorders. World Neurosurg. 2013;80(3–4):S30 e17-25.
    1. Dell'Osso B, Porta M, Servello D, Altamura AC. Deep Brain Stimulation device removal after scar picking behaviors in a patient with treatment-resistant obsessive compulsive disorder. Brain Stimul. 2013;6(1):96–98. doi: 10.1016/j.brs.2012.01.007.
    1. Vora AK, Ward H, Foote KD, Goodman WK, Okun MS. Rebound symptoms following battery depletion in the NIH OCD DBS cohort: clinical and reimbursement issues. Brain Stimul. 2012;5(4):599–604. doi: 10.1016/j.brs.2011.10.004.
    1. Witt K, Kuhn J, Timmermann L, Zurowski M, Woopen C. Deep Brain Stimulation and the Search for Identity. Neuroethics. 2013;6:499–511. doi: 10.1007/s12152-011-9100-1.
    1. Garnaat SL, Greenberg BD, Sibrava NJ, Goodman WK, Mancebo MC, Eisen JL, Rasmussen SA. Who Qualifies for Deep Brain Stimulation for OCD? Data From a Naturalistic Clinical Sample. J Neuropsychiatry Clin Neurosci. 2014;26(1):81–86.
    1. Riva-Posse P, Choi KS, Holtzheimer PE, McIntyre CC, Gross RE, Chaturvedi A, Crowell AL, Garlow SJ, Rajendra JK, Mayberg HS: Defining Critical White Matter Pathways Mediating Successful Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Depression.Biol Psychiat 2014, Advanced online publication. Retrieved from doi:10.1016/j.biopsych.2014.03.029.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅